Evaluation of APOE Genotype and Vascular Risk Factors As Prognostic and Risk Factors for Alzheimer’s Disease and Their Influence On Age of Symptoms Onset
Author(s) -
Gabriela Novotni,
Milena Jakimovska,
Dijana PlaseskaKaranfilska,
Nikolina Tanovska,
Igor Kuzmanovski,
Vasko Aleksovski,
Katerina Karanfilovik,
Natalija Baneva-Dolnenec,
Marijana Stankovic,
Milos Milutinovik,
Svetlana Iloski,
Rosalinda Isjanovska,
Biljana Blaževska–Stoilkovska,
A. Duma,
Antoni Novotni
Publication year - 2019
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2019.166
Subject(s) - medicine , apolipoprotein e , diabetes mellitus , dementia , disease , risk factor , dyslipidemia , vascular dementia , genotyping , type 2 diabetes mellitus , genotype , allele , endocrinology , genetics , gene , biology
Alzheimer's disease (AD), the most common cause of dementia, is evolving to become a threatening epidemy of the 21 st century. Only 21% of the predicted number of AD patients in Macedonia have been diagnosed and treated, which means that almost 80% are underdiagnosed or misdiagnosed. Apolipoprotein E gene ( APOE ) is recognised as the strongest genetic risk factor for sporadic AD. Whether and when Alzheimer's disease develops, depends on the very complex interaction between genetic and modifiable risk factors. It has been known that vascular factors like hypertension, diabetes mellitus, hypercholesterolemia and obesity increase the risk of developing both AD, vascular dementia and mixed AD and vascular pathology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom